Literature DB >> 20209612

Invasive carcinoma of the uterine cervix associated with pregnancy: 90 years of experience.

B Folke Pettersson1, Sonia Andersson, Kristina Hellman, Ann-Cathrin Hellström.   

Abstract

BACKGROUND: This study is a representation of 90 years of experience with carcinoma of the uterine cervix in pregnancy. The objective was to retrospectively study changes in the distribution of cervical carcinoma (CC) by age, disease stage, histopathology, survival, and the development of second primary cancers.
METHODS: Altogether, 18,474 women with newly diagnosed CC were examined and treated at the Radiumhemmet between 1914 and 2004, including 9247 women who were of a childbearing age (<50 years) and 219 women who were pregnant.
RESULTS: The mean patient age declined from 35 years (during 1914-1943) to 32.2 years (during 1960-2004). Similarly, the age range changed from ages 23 to 51 years (during 1914-1943) to ages 21 to 47 years (during 1960-2004). The relative incidence for all women aged <50 years who were treated for CC dropped considerably from 4.2% (during 1914-1943) to 1.2% (during 1960-2004), which translated into a reduction of by approximately 66%. At the time of diagnosis, stage I CC was observed in 75.6% of patients during 1960 to 2004 compared with 24.8% of patients during 1914 to 1943. The 10-year actuarial survival rate improved significantly during the study period from 27% (1914-2004) to 79% (1960-2004). The 10-year cause-specific cumulative actuarial survival rate for 41 women who were treated during 1960 to 2004 did not differ statistically from the rate for an age-matched, stage-matched, and histopathology-matched control series from the total cohort of women with CC who were treated at the Radiumhemmet during the same period (log-rank test; P = .85).
CONCLUSIONS: During the study period, the incidence of CC during pregnancy declined, the cases were discovered at earlier stages, and survival improved. Furthermore, there was no increase in second primary cancers, and pregnancy did not appear to influence prognosis. (c) 2010 American Cancer Society.

Entities:  

Mesh:

Year:  2010        PMID: 20209612     DOI: 10.1002/cncr.24971

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Challenges in the management of neuroendocrine cervical cancer during pregnancy: A case report.

Authors:  Blanca Gil-Ibañez; Purificacion Regueiro; Elisa Llurba; Lorena Fariñas-Madrid; Angel Garcia; Berta Diaz-Feijoo
Journal:  Mol Clin Oncol       Date:  2018-09-13

2.  Pregnancy-associated cancer and the risk of second primary cancer.

Authors:  Lene Mellemkjær; Simone Eibye; Vanna Albieri; Susanne K Kjær; John D Boice
Journal:  Cancer Causes Control       Date:  2021-10-13       Impact factor: 2.506

3.  Cervical cancer in the screening era: who fell victim in spite of successful screening programs?

Authors:  B Folke Pettersson; Kristina Hellman; Roxane Vaziri; Sonia Andersson; Ann-Cathrin Hellström
Journal:  J Gynecol Oncol       Date:  2011-06-30       Impact factor: 4.401

4.  Wrong place at the wrong time: A case of cervical embryonal rhabdomyosarcoma in pregnancy.

Authors:  Katayoun Taghavi; Peter Sykes; Carrie Innes; David Gibbs; Lauree Hunter; Wendy McBurnie; Bryony Simcock
Journal:  Gynecol Oncol Rep       Date:  2015-04-18

5.  Conservative Treatment of Stage IA1 Adenocarcinoma of the Uterine Cervix during Pregnancy: Case Report and Review of the Literature.

Authors:  Francesco Sopracordevole; Diego Rossi; Jacopo Di Giuseppe; Marta Angelini; Pierino Boschian-Bailo; Monica Buttignol; Andrea Ciavattini
Journal:  Case Rep Obstet Gynecol       Date:  2014-03-16

6.  Trends in Cervical Cancer Among Delivery-Related Discharges and its Impact on Maternal-Infant Birth Outcomes (United States, 1998-2009).

Authors:  Mulubrhan F Mogos; Jason L Salemi; Dawood H Sultan; Melissa M Shelton; Hamisu M Salihu
Journal:  Open Nurs J       Date:  2015-11-16

7.  Conservative treatment of coexisting microinvasive squamous and adenocarcinoma of the cervix: report of two cases and literature review.

Authors:  Francesco Sopracordevole; Jacopo Di Giuseppe; Silvia Cervo; Monica Buttignol; Giorgio Giorda; Andrea Ciavattini; Vincenzo Canzonieri
Journal:  Onco Targets Ther       Date:  2016-01-27       Impact factor: 4.147

8.  Results of cytology and high-risk human papillomavirus testing in females with cervical adenocarcinoma in situ.

Authors:  Sonia Andersson; Miriam Mints; Erik Wilander
Journal:  Oncol Lett       Date:  2013-05-15       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.